Back to top
more

Edwards Lifesciences (EW)

(Real Time Quote from BATS)

$78.66 USD

78.66
2,821,748

-0.58 (-0.73%)

Updated Aug 6, 2025 03:54 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value F Growth A Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 40% (148 out of 246)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Express Scripts Rides High on Increased Generic Utilization

by Zacks Equity Research

On Jul 10, we issued an updated research report on St. Louis, MO-based pharmacy benefit manager Express Scripts Holding Company (ESRX).

    Zacks Equity Research

    PAREXEL (PRXL) Gets CEO Cancer Gold Standard Accreditation

    by Zacks Equity Research

    PAREXEL International Corporation (PRXL) was recently nominated as a CEO Cancer Gold Standard employer by CEO Roundtable on Cancer.

      Zacks Equity Research

      Neogen Introduces Test for Listeria in Environmental Samples

      by Zacks Equity Research

      Neogen Corporation (NEOG) recently developed Listeria Right Now test system.

        Zacks Equity Research

        MedTech Industry Outlook - July 2017

        by Zacks Equity Research

        The overall expectation is that President Trump's legislative change for MedTech will result in lower taxes and regulation for the industry as a whole.

          Panel Of Zacks Experts headshot

          Top Stock Picks for the Week of May 29th

          by Panel Of Zacks Experts

          A Value and Medical Growth Play to Consider.

            Zacks Equity Research

            Why Is Edwards Lifesciences (EW) Up 4.5% Since the Last Earnings Report?

            by Zacks Equity Research

            EW reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

              Zacks Equity Research

              Why Edwards Lifesciences (EW) Isn't Done Growing Earnings Yet

              by Zacks Equity Research

              Edwards Lifesciences (EW) seems well-positioned for future earnings growth and it is seeing rising earnings estimates as well, coupled with a solid Zacks Rank.

                Zacks Equity Research

                Zacks Investment Ideas feature highlights: Regeneron, Edwards Lifesciences, Alexion Pharmaceuticals, Align Technology and Centene

                by Zacks Equity Research

                Zacks Investment Ideas feature highlights: Regeneron, Edwards Lifesciences, Alexion Pharmaceuticals, Align Technology and Centene

                  Kevin Cook headshot

                  5 Healthcare Innovators I'm Still Buying

                  by Kevin Cook

                  When you think long-term about the megatrends in healthcare, it makes picking winners easier

                    Zacks Equity Research

                    Edwards Lifesciences (EW) Tops Q1 Earnings, Updates '17 View

                    by Zacks Equity Research

                    Edwards Lifesciences Corp. (EW) reported first-quarter 2017 adjusted earnings per share (EPS) of 94 cents, which surpassed the Zacks Consensus Estimate by 14.6%.

                      Zacks Equity Research

                      Medical Product Stocks Earnings on Apr 25: SYK, EW, LH

                      by Zacks Equity Research

                      Medical is one of the broader sectors among the 16 Zacks sectors that are expected to report earnings growth in the first quarter.

                        Zacks Equity Research

                        Edward Lifesciences (EW) Q1 Earnings: A Surprise in Store?

                        by Zacks Equity Research

                        Edward Lifesciences Corp. (EW) is scheduled to report first-quarter 2017 earnings results after market close on Apr 25.

                          Tracey Ryniec headshot

                          Should You Make a Bet on the Healthcare Stocks?

                          by Tracey Ryniec

                          The healthcare industry is much more than Obamacare and drug prices as many companies are using new technologies to create breakthroughs in medicine.

                            Zacks Equity Research

                            Why Is Edwards (EW) Up 4.1% Since the Last Earnings Report?

                            by Zacks Equity Research

                            Edwards (EW) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

                              Swarup Gupta headshot

                              5 Biggest Winners from the Obamacare Replacement Bill Pushback

                              by Swarup Gupta

                              This setback was largely an outcome of the lack of consensus among various factions of the GOP.

                                Zacks Equity Research

                                Edwards Lifesciences (EW) Beats on Earnings & Sales in Q4

                                by Zacks Equity Research

                                Edwards Lifesciences Corp. (EW) reported fourth-quarter 2016 adjusted earnings per share (EPS) of 75 cents, which surpassed the Zacks Consensus Estimate by 5.6%.

                                  Zacks Equity Research

                                  Edward Lifesciences (EW): What's in Store in Q4 Earnings?

                                  by Zacks Equity Research

                                  Edward Lifesciences Corp. (EW) is scheduled to report fourth-quarter and full-year 2016 earnings results after market close on Feb 1, 2017.

                                    Sheraz Mian headshot

                                    The Clouds Will Lift After the Vote

                                    by Sheraz Mian

                                    The tightening of polls in recent days has added to uncertainty, but we will see a collective sigh of relief after a clear verdict.

                                      Sheraz Mian headshot

                                      Analyst Reports for Sprint, Eli Lilly, & United Technologies

                                      by Sheraz Mian

                                      Today's Research Daily features new research reports on 16 major stocks, including United Technologies (UTX), Sprint (S) and Eli Lilly (LLY).

                                        Zacks Equity Research

                                        4 Med Instrument Stocks for Q3 Earnings amid Election Chaos

                                        by Zacks Equity Research

                                        The medical device sector is positioned for impressive growth in the near term.

                                          Sheraz Mian headshot

                                          The Uncertainty of a Close Election

                                          by Sheraz Mian

                                          The uncertainty of the tight election notwithstanding, stocks will rejoice as the results come in, irrespective of who the winner is.

                                            Kevin Cook headshot

                                            Bull of the Day: Edwards Lifesciences (EW)

                                            by Kevin Cook

                                            Heart patients and investors around the world are grateful for this valve replacement technology

                                              Zacks Equity Research

                                              MedTech Industry Stock Outlook - July 2016

                                              by Zacks Equity Research

                                              Two full quarters of 2016 are behind us and, while we await second quarter results over the coming weeks, we hardly expect a change in trend in the bullish MedTech sector.

                                                Kevin Cook headshot

                                                Bull of the Day: Edwards Lifesciences (EW)

                                                by Kevin Cook

                                                EW wins as more physicians are choosing minimally invasive heart procedures for their patients

                                                  Jeremy Mullin headshot

                                                  4 Stocks to Buy on Pullbacks

                                                  by Jeremy Mullin

                                                  The next market pullback will create opportunities to enter performing stocks.